HDAC4 repressed the expression of CDKN1A in human cancer cells, and silencing of HDAC4 induced CDKN1A expression and inhibited cancer cell growth in vitro and in an in vivo human GBM model [39]. This evidence concerns the gene CDKN1A and glioblastoma.